2015 Annual Meeting | Pain and Palliative Care
| 01:00 PM - 02:45 PM | Abstract |
002 - Clinical and molecular profiling of muscle pain in myotonic dystrophy type 2
|
| 01:00 PM - 02:45 PM | Abstract |
003 - Alterations in Brain Gray Matter Volume are Associated with Reduced Evoked-Pain Connectivity following Acute Pregabalin Administration
Tudor Puiu |
| 01:00 PM - 02:45 PM | Abstract |
004 - Gene Therapy for Neuropathic Pain by Silencing of TNF-α Expression with Lentiviral Vectors Targeting the Dorsal Root Ganglion in Mice.
|
| 01:00 PM - 02:45 PM | Abstract |
005 - Chronic Regional Pain Syndrome: A Preliminary report on molecular mechanisms and structural correlates
Beth B. Hogans, MD, PhD |
| 01:00 PM - 02:45 PM | Abstract |
006 - Do Social Media improve dissemination of Clinical Practice Guidelines (CPG)?
Thomas Getchius |
| 01:00 PM - 02:45 PM | Abstract |
007 - Advance directives and palliative care in ALS patients. The Piedmont and Valle d’Aosta register experience
Andrea Calvo, MD, PhD, FAAN |
| Ricardo Cruciani, MD | No disclosure on file |
| Misha-Miroslav Backonja, MD | Dr. Backonja has nothing to disclose. |
| Gary S. Gronseth, MD, FAAN | Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN. |
| Ruth-Ann Marrie, MD, PhD | The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC. |
| No disclosure on file | |
| Simone Spuler, MD | No disclosure on file |
| Andrea Calvo, MD, PhD, FAAN | Dr. Calvo has nothing to disclose. |
| Umberto Manera, MD | Dr. Manera has nothing to disclose. |
| Richard M. Dubinsky, MD, MPH, FAAN | Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Neurocrine. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals. |
| Pushpa Narayanaswami, MD, MBBS, FAAN | Dr. Narayanaswami has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving as a Consultant for CVS. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx USA. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD pharma. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immuneabs. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve, Wiley. Dr. Narayanaswami has stock in Dr. Reddys laboratories. Dr. Narayanaswami has stock in Doximity. The institution of Dr. Narayanaswami has received research support from Alexion. The institution of Dr. Narayanaswami has received research support from Dianthus. The institution of Dr. Narayanaswami has received research support from Dianthus. Dr. Narayanaswami has received publishing royalties from a publication relating to health care. Dr. Narayanaswami has a non-compensated relationship as a Member, Medical and Scientific Council with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Narayanaswami has a non-compensated relationship as a Member, Finance Committee with AANEM that is relevant to AAN interests or activities. |
| Julie Cox | No disclosure on file |
| Beth B. Hogans, MD, PhD | Dr. Hogans has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Academy of Pain Medicine. The institution of Dr. Hogans has received research support from VA Office of Research and Development. Dr. Hogans has received intellectual property interests from a discovery or technology relating to health care. Dr. Hogans has received publishing royalties from a publication relating to health care. Dr. Hogans has received publishing royalties from a publication relating to health care. Dr. Hogans has a non-compensated relationship as a Grant reviewer with Veterans Affairs Office of Research and Development that is relevant to AAN interests or activities. Dr. Hogans has a non-compensated relationship as a Grant reviewer with National Institutes of Health that is relevant to AAN interests or activities. |
| Cristina Moglia | Cristina Moglia has nothing to disclose. |
| Thomas Getchius | No disclosure on file |
| Rebecca Penfold Murray | No disclosure on file |
| Richard Harris | Richard Harris has nothing to disclose. |
| Tudor Puiu | No disclosure on file |
| Eric Ichesco | Eric Ichesco has nothing to disclose. |
| Jerzy P. Szaflarski, MD, PhD, FAAN | Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea. |
| Antonio Canosa | Antonio Canosa has nothing to disclose. |
| Christopher Bever, Jr., MD, MBA, FAAN | No disclosure on file |
| Adriano Chio, MD, FAAN | Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. |